Top Los Angeles, CA Biotech Companies (58)
Ambry Genetics is a company built by scientists, genetic counselors and physicians, dedicated to leading the clinical genomic diagnostic industry. Ambry boasts the largest genetic sequencing lab in the world; is CAP-accredited, CLIA-licensed and, as part of the Konica Minolta family, has access to the most complete suite of diagnostic technology in the world. Ambry Genetics' scope of clients includes some of the world's most respected academic institutions, pharmaceutical companies and leading treatment hospitals. Our experience, technology and dedication to science make us a trusted source for all clinical genetic testing, and an ideal partner for developing precision medicine solutions. Patients are at the core of everything we do, which is why Ambry partners with several non-profit organizations so that we can help both patients and clinicians alike find answers.
CARI Health is developing the next generation of Remote Medication Monitors that will allow clinicians to prescribe medications and receive real-time reporting on medication levels. CARI’s small, wireless sensors are worn on the patient’s skin and continuously monitor medication levels, sending alerts when necessary. With a CARI Remote Medication Monitor clinicians can provide precision care in this new era of telehealth medicine.
AmpliPhi Biosciences is focused on developing novel bacteriophage-based therapeutics.
Ocular is an Anti- Money Laundering (AML) compliance platform that provides instant verification of a customer`s background (KYC). The platform leverages cryptographic security mechanisms employed in distributed ledger technologies to ensure that data cannot be tampered with, while allowing users full control over how their data is stored and shared. The system is user-friendly for applicants while adhering to strict AML policy guidelines. Ocular integrates traditional name and personal data background checks with state-of-the-art identity verification mechanisms such as facial and voice recognition. This safeguards against ID theft, false registrations, Sybil attacks and other attacks which compromise and circumvent compliance. Ocular uses advanced technologies such as artificial intelligence (AI) and machine learning to dynamically monitor and upgrade its capabilities and defenses in the face of an ever-changing landscape of cyber security. The objective of Ocular is to provide parties a transparent mechanism to verify and validate one another, to prevent fraud and expose fraudulent activities. Ocular aim to be the de-facto standard for multi purpose, highly customizable and configurable solutions that bridges traditional finance with crypto and satisfies compliance requirements at the highest possible levels. The Ocular solution is the fastest way to achieve full AML compliance for your customers!
Kernel creates the interfaces and insights necessary to unlock the greatest scientific unknown: the inner workings of the human brain and mind. Kernel is a full-stack neurotech company founded in 2016 with the mandate to do something that will change the world. Kernel is leveraging the best non-invasive brain scanning techniques to create next-generation technologies that dramatically expand the accuracy, frequency, and environments in which cognitive activity can be monitored. Our proprietary technology is designed in-house, and built from the ground up, with neuroscientists, physicists, and engineers controlling every step of the process, from chip design to optics; control software to machine learning; experimental design to analysis. Most noninvasive methods for recording brain signals measure electromagnetic fields generated by groups of neurons, or detect small changes in blood oxygenation (which correlate well to nearby neural activity). But existing technology in both of these technologies are rife with drawbacks, limitations or shortcomings. Kernel is building the next generation of both of these modalities, leveraging the strengths of OP-MEG (optically-pumped magnetoencephalography) and TD-fNIRS (time-domain functional near-infrared spectroscopy) into products that offer the following benefits: • High-quality neural signal • Full-head coverage • Scalability • Relatively low cost • Natural environments, stimuli, and interactions • Freedom of user motion
Fluxergy was founded 10 years ago with a vision to democratize the world of laboratory testing, by making testing more accessible and affordable. Fluxergy’s platform technology enables us to understand our world and our health in ways that were never possible before. Fluxergy is developing a platform with multi-modal detection technologies which bring the variety of tests found in the central lab to the palm of your hand – This includes molecular testing like PCR, Immunochemistry and chemistry testing, and microscopy testing such as cytometry. Fluxergy’s platform vision is the detection of genes, proteins, small molecules, and cells with the same analyzer. The automated, sample-to-answer workflows can be customized for specific sample and testing methods.
Gather Labs is a High Complexity CLIA Lab and wellness boutique focused on sparking joy in the diagnostic experience. We offer same day resulting for all diagnostic tests.
Phenomenex is a manufacturer and distributor of high-value consumables for the separation sciences.
Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free. Agendia’s assays can be ordered on core biopsies or surgical specimens to inform pre- and post-operative treatment decisions. For more information on Agendia’s assays and ongoing trials, please visit www.agendia.com. For view our social media policies, please visit https://agendia.com/legal-compliance/
Scripps Research is a leader in the discovery and application of biomedical breakthroughs that improve human health. As the world's largest independent non-profit biomedical research facility, we expand the frontiers of science and education and create hope for millions. Scripps Research is ranked #1 for innovation by the Nature Index.
Viridos (formerly Synthetic Genomics, Inc) is a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to mitigate climate change. Our unparalleled understanding of algal genetics and ability to translate innovation from lab to field underpins our initial deployment: a scalable platform to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping. Building on a legacy of genomic firsts, our team of scientists and engineersare shaping new pathways toward a sustainable bioeconomy. To learn more, visit us at Viridos.com.
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases. With the team’s experience and scientific expertise in new drug development, Angitia is dedicated to bringing innovative therapeutics to help patients in need
Progenesis is the first company in the US to introduce Next Generation Sequencing (NGS) for Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic disorders (PGT-M). We offer embryo screening for many common diseases including cystic fibrosis, Fragile X syndrome, sickle cell disease, and Tay-Sachs disease. We have introduced the most accurate test in the IVF field for 24-chromosome aneuploidy screening and single gene disorder. At Progenesis, we believe in innovation. Our expert scientists are constantly working to improve our products through research and development. Our goal is to provide our patients with the latest, most advanced technology and information to equip them with the best tools to build healthy families. For more information, please visit www.progenesis.com. #Progenesis #Biotechnology #GeneticTesting #Innovation #IVF #Infertility #Diagnosis
Exsomed’s mission is to develop minimally-invasive, innovative solutions to enhance extremity implant procedures.
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers.
Varda Space Industries was founded in 2020 with the goal of manufacturing products in space to benefit life on Earth. Co-founders Will Bruey and Delian Asparouhov imagined a world where space could be leveraged not only for storytelling and awe, but for its economic benefits. Varda was created as a platform for in-space manufacturing, with a range of real-life, on-Earth use cases. Today, we are accelerating innovation in space through our microgravity manufacturing platform, with applications including pharmaceuticals, hypersonic testing, and fiber optics. Varda is headquartered in El Segundo, California and has received venture funding from investors including Khosla Ventures, Lux Capital, Founders Fund, Caffeinated Capital, General Catalyst, and Also Capital.
Siragen Pharmaceuticals is an innovative biotechnology company.
EnteroMedics® Inc. (NASDAQ: ETRM) is the developer of in-class weight loss treatments for obesity and obesity related risk factors.
Chemistry is the key to drug discovery, but chemical data is stuck in the twentieth century. We’re generating precise chemical datasets purpose-built to propel drug discovery into the information age — and we’re doing it on a larger scale and faster than has ever before been possible. Terray Therapeutics is a biotechnology company led by pioneers and long-time leaders in artificial intelligence, synthetic (medicinal) chemistry, biology and preclinical development, automation, and nanotechnology. Chemical datasets generated using our novel ultra-dense microarray technology work seamlessly with our integrated machine learning and computational platform to systematically map biochemical interactions between small molecules and causes of disease. Iterative cycles of virtual molecular design and experimentation power AI and machine learning models, which in turn guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise with every cycle, we can answer an unprecedented array of questions — deriving insights that enable us to predictably create drugs for patients in need.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen. See our Community Guidelines: bit.ly/smcgl See our Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.
Work Your Passion. Live Your Purpose.
